# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
0, Journal, 0, 14, "Eye ( Lond ) .", "", "<http://ctro/data#Publication_52445> <http://ctro/data#hasJournal> \"Eye ( Lond ) .\"."
1, PublicationYear, 15, 19, "2005", "", "<http://ctro/data#Publication_52445> <http://ctro/data#hasPublicationYear> \"2005\"."
45, Brimonidine, 47, 58, "Brimonidine", "", "<http://ctro/data#Medication_52535> <http://ctro/data#hasDrug> <http://ctro/data#Brimonidine>."
2, Title, 47, 218, "Brimonidine 0 . 2 % vs unoprostone 0 . 15 % both added to timolol maleate 0 . 5 % given twice daily to patients with primary open - angle glaucoma or ocular hypertension .", "", "<http://ctro/data#Publication_52445> <http://ctro/data#hasTitle> \"Brimonidine 0 . 2 % vs unoprostone 0 . 15 % both added to timolol maleate 0 . 5 % given twice daily to patients with primary open - angle glaucoma or ocular hypertension .\"."
48, DoseValue, 59, 64, "0 . 2", "", "<http://ctro/data#Medication_52535> <http://ctro/data#hasDoseValue> \"0 . 2\"."
51, Percentage, 65, 66, "%", "", "<http://ctro/data#Medication_52535> <http://ctro/data#hasDoseUnit> <http://ctro/data#Percentage>."
46, Unoprostone, 70, 81, "unoprostone", "", "<http://ctro/data#Medication_52542> <http://ctro/data#hasDrug> <http://ctro/data#Unoprostone>."
49, DoseValue, 82, 88, "0 . 15", "", "<http://ctro/data#Medication_52542> <http://ctro/data#hasDoseValue> \"0 . 15\"."
52, Percentage, 89, 90, "%", "", "<http://ctro/data#Medication_52542> <http://ctro/data#hasDoseUnit> <http://ctro/data#Percentage>."
47, Timolol, 105, 120, "timolol maleate", "", "<http://ctro/data#Medication_52528> <http://ctro/data#hasDrug> <http://ctro/data#Timolol>."
50, DoseValue, 121, 126, "0 . 5", "", "<http://ctro/data#Medication_52528> <http://ctro/data#hasDoseValue> \"0 . 5\"."
53, Percentage, 127, 128, "%", "", "<http://ctro/data#Medication_52542> <http://ctro/data#hasDoseUnit> <http://ctro/data#Percentage>."
54, Frequency, 135, 146, "twice daily", "", "<http://ctro/data#Intervention_52516> <http://ctro/data#hasFrequency> \"twice daily\". <http://ctro/data#Intervention_52522> <http://ctro/data#hasFrequency> \"twice daily\"."
85404, Precondition, 150, 216, "patients with primary open - angle glaucoma or ocular hypertension", "", "<http://ctro/data#Population_52480> <http://ctro/data#hasPrecondition> \"patients with primary open - angle glaucoma or ocular hypertension\"."
55, Primary_OpenAngleGlaucoma, 164, 193, "primary open - angle glaucoma", "", "<http://ctro/data#ClinicalTrial_52458> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Primary_OpenAngleGlaucoma>."
3, OcularHypertension, 197, 216, "ocular hypertension", "", "<http://ctro/data#ClinicalTrial_52458> <http://ctro/data#analysesHealthCondition> <http://ctro/data#OcularHypertension>."
4, Author, 219, 228, "Sharpe ED", "", "<http://ctro/data#Publication_52445> <http://ctro/data#hasAuthor> \"Sharpe ED\"."
5, Author, 237, 245, "Henry CJ", "", "<http://ctro/data#Publication_52445> <http://ctro/data#hasAuthor> \"Henry CJ\"."
6, Author, 248, 258, "Mundorf TK", "", "<http://ctro/data#Publication_52445> <http://ctro/data#hasAuthor> \"Mundorf TK\"."
7, Author, 261, 267, "Day DG", "", "<http://ctro/data#Publication_52445> <http://ctro/data#hasAuthor> \"Day DG\"."
8, Author, 270, 280, "Stewart JA", "", "<http://ctro/data#Publication_52445> <http://ctro/data#hasAuthor> \"Stewart JA\"."
9, Author, 283, 293, "Jenkins JN", "", "<http://ctro/data#Publication_52445> <http://ctro/data#hasAuthor> \"Jenkins JN\"."
10, Author, 296, 306, "Stewart WC", "", "<http://ctro/data#Publication_52445> <http://ctro/data#hasAuthor> \"Stewart WC\"."
11, USA, 383, 386, "USA", "", "<http://ctro/data#Population_52480> <http://ctro/data#hasCountry> <http://ctro/data#USA>."
12, ObjectiveDescription, 399, 545, "To compare the efficacy and safety of brimonidine 0 . 2 % vs unoprostone 0 . 15 % , both added to timolol maleate 0 . 5 % each given twice daily .", "", "<http://ctro/data#ClinicalTrial_52458> <http://ctro/data#hasObjectiveDescription> \"To compare the efficacy and safety of brimonidine 0 . 2 % vs unoprostone 0 . 15 % , both added to timolol maleate 0 . 5 % each given twice daily .\"."
56, Brimonidine, 437, 448, "brimonidine", "", 
59, DoseValue, 449, 454, "0 . 2", "", 
62, Percentage, 455, 456, "%", "", 
57, Unoprostone, 460, 471, "unoprostone", "", 
60, DoseValue, 472, 478, "0 . 15", "", 
63, Percentage, 479, 480, "%", "", 
58, Timolol, 497, 512, "timolol maleate", "", 
61, DoseValue, 513, 518, "0 . 5", "", 
64, Percentage, 519, 520, "%", "", 
65, Frequency, 532, 543, "twice daily", "", 
124, Prospective, 564, 575, "prospective", "", "<http://ctro/data#ClinicalTrial_52458> <http://ctro/data#hasCTDesign> <http://ctro/data#Prospective>."
14, Multicenter, 578, 593, "multi - centred", "", "<http://ctro/data#ClinicalTrial_52458> <http://ctro/data#hasCTDesign> <http://ctro/data#Multicenter>."
15, DoubleBlind, 596, 611, "double - masked", "", "<http://ctro/data#ClinicalTrial_52458> <http://ctro/data#hasCTDesign> <http://ctro/data#DoubleBlind>."
16, Crossover, 614, 623, "crossover", "", "<http://ctro/data#ClinicalTrial_52458> <http://ctro/data#hasCTDesign> <http://ctro/data#Crossover>."
17, Randomized, 651, 661, "randomized", "", "<http://ctro/data#ClinicalTrial_52458> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
18, Duration, 691, 699, "6 - week", "", "<http://ctro/data#ClinicalTrial_52458> <http://ctro/data#hasCTduration> \"6 - week\"."
66, Crossover, 728, 740, "crossed over", "", 
85407, TimePoint, 800, 804, "0800", "", 
85408, TimePoint, 807, 811, "1000", "", 
85409, TimePoint, 814, 818, "1600", "", 
85410, TimePoint, 821, 825, "1800", "", 
85411, TimePoint, 832, 836, "2000", "", 
85406, TimePoint, 842, 850, "baseline", "", 
19, NumberPatientsCT, 912, 914, "33", "", "<http://ctro/data#ClinicalTrial_52458> <http://ctro/data#hasNumberPatientsCT> \"33\"."
20, FinalNumPatientsCT, 947, 949, "29", "", "<http://ctro/data#ClinicalTrial_52458> <http://ctro/data#hasFinalNumberPatientsCT> \"29\"."
67, Trough_IOP, 975, 1002, "trough intraocular pressure", "", "<http://ctro/data#Endpoint_52488> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#Trough_IOP>."
137, IOP, 1005, 1008, "IOP", "", 
21, BaseLineValue, 1015, 1021, "23 . 3", "", "<http://ctro/data#Outcome_52551> <http://ctro/data#hasBaselineValue> \"23 . 3\". <http://ctro/data#Outcome_52578> <http://ctro/data#hasBaselineValue> \"23 . 3\"."
140, SdDevBL, 1028, 1033, "2 . 4", "", "<http://ctro/data#Outcome_52551> <http://ctro/data#hasSdDevBL> \"2 . 4\". <http://ctro/data#Outcome_52578> <http://ctro/data#hasSdDevBL> \"2 . 4\"."
23, Diurnal_IOP, 1042, 1059, "diurnal curve IOP", "", "<http://ctro/data#Endpoint_52493> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#Diurnal_IOP>."
24, BaseLineValue, 1064, 1070, "22 . 0", "", "<http://ctro/data#Outcome_52605> <http://ctro/data#hasBaselineValue> \"22 . 0\". <http://ctro/data#Outcome_52632> <http://ctro/data#hasBaselineValue> \"22 . 0\"."
143, SdDevBL, 1077, 1082, "1 . 3", "", "<http://ctro/data#Outcome_52605> <http://ctro/data#hasSdDevBL> \"1 . 3\". <http://ctro/data#Outcome_52632> <http://ctro/data#hasSdDevBL> \"1 . 3\"."
26, mmHg, 1083, 1087, "mmHg", "", "<http://ctro/data#Endpoint_52488> <http://ctro/data#hasBaselineUnit> <http://ctro/data#mmHg>. <http://ctro/data#Endpoint_52493> <http://ctro/data#hasBaselineUnit> <http://ctro/data#mmHg>."
69, Brimonidine, 1098, 1109, "brimonidine", "", 
70, Timolol, 1114, 1129, "timolol maleate", "", 
71, Trough_IOP, 1152, 1162, "trough IOP", "", 
27, ResultMeasuredValue, 1167, 1173, "21 . 6", "", "<http://ctro/data#Outcome_52551> <http://ctro/data#hasResultMeasuredValue> \"21 . 6\"."
97106, SdDevResValue, 1180, 1185, "3 . 3", "", "<http://ctro/data#Outcome_52551> <http://ctro/data#hasSdDevResValue> \"3 . 3\"."
72, Diurnal_IOP, 1194, 1211, "diurnal curve IOP", "", 
29, ResultMeasuredValue, 1216, 1222, "19 . 8", "", "<http://ctro/data#Outcome_52605> <http://ctro/data#hasResultMeasuredValue> \"19 . 8\"."
97107, SdDevResValue, 1229, 1234, "2 . 1", "", "<http://ctro/data#Outcome_52605> <http://ctro/data#hasSdDevResValue> \"2 . 1\"."
31, mmHg, 1235, 1239, "mmHg", "", 
73, Timolol, 1252, 1259, "timolol", "", 
74, Unoprostone, 1264, 1275, "unoprostone", "", 
75, Trough_IOP, 1295, 1305, "trough IOP", "", 
32, ResultMeasuredValue, 1309, 1315, "20 . 9", "", "<http://ctro/data#Outcome_52578> <http://ctro/data#hasResultMeasuredValue> \"20 . 9\"."
97108, SdDevResValue, 1322, 1327, "3 . 8", "", "<http://ctro/data#Outcome_52578> <http://ctro/data#hasSdDevResValue> \"3 . 8\"."
76, Diurnal_IOP, 1334, 1351, "diurnal curve IOP", "", 
34, ResultMeasuredValue, 1355, 1361, "19 . 3", "", "<http://ctro/data#Outcome_52632> <http://ctro/data#hasResultMeasuredValue> \"19 . 3\"."
97109, SdDevResValue, 1368, 1373, "2 . 4", "", "<http://ctro/data#Outcome_52632> <http://ctro/data#hasSdDevResValue> \"2 . 4\"."
36, mmHg, 1374, 1378, "mmHg", "", 
164, ObservedResult, 1381, 1534, "There was no significant difference between treatment groups at any time point for the diurnal curve , or in the reduction from baseline ( P > 0 . 05 ) .", "", 
77, Diurnal_IOP, 1468, 1481, "diurnal curve", "", 
42, PvalueDiff, 1520, 1530, "P > 0 . 05", "", "<http://ctro/data#DiffBetweenGroups_52659> <http://ctro/data#hasPvalueDiff> \"P > 0 . 05\"."
78, IOP, 1586, 1589, "IOP", "", 
85412, TimePoint, 1607, 1613, "1800 h", "", 
39, ObservedResult, 1749, 1852, "more dryness ( P = 0 . 02 ) and burning upon instillation ( P < 0 . 0001 ) with unoprostone by survey .", "", "<http://ctro/data#Outcome_112506> <http://ctro/data#hasObservedResult> \"more dryness ( P = 0 . 02 ) and burning upon instillation ( P < 0 . 0001 ) with unoprostone by survey .\". <http://ctro/data#Outcome_112533> <http://ctro/data#hasObservedResult> \"more dryness ( P = 0 . 02 ) and burning upon instillation ( P < 0 . 0001 ) with unoprostone by survey .\"."
37, EndPointDescription, 1754, 1761, "dryness", "", "<http://ctro/data#EndPointDescription_52670> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_52669> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_52670>."
85413, PvalueDiff, 1764, 1774, "P = 0 . 02", "", 
38, EndPointDescription, 1781, 1788, "burning", "", "<http://ctro/data#EndPointDescription_52675> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_52674> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_52675>."
169, PvalueDiff, 1811, 1821, "< 0 . 0001", "", 
79, Unoprostone, 1829, 1840, "unoprostone", "", 
40, ConclusionComment, 1866, 2017, "Brimonidine 0 . 2 % or unoprostone 0 . 15 % added to timolol maleate 0 . 5 % provide similar efficacy and safety throughout the daytime diurnal curve .", "", "<http://ctro/data#ClinicalTrial_52458> <http://ctro/data#hasConclusionComment> \"Brimonidine 0 . 2 % or unoprostone 0 . 15 % added to timolol maleate 0 . 5 % provide similar efficacy and safety throughout the daytime diurnal curve .\"."
80, Brimonidine, 1866, 1877, "Brimonidine", "", 
83, DoseValue, 1878, 1883, "0 . 2", "", 
86, Percentage, 1884, 1885, "%", "", 
81, Unoprostone, 1889, 1900, "unoprostone", "", 
84, DoseValue, 1901, 1907, "0 . 15", "", 
87, Percentage, 1908, 1909, "%", "", 
82, Timolol, 1919, 1934, "timolol maleate", "", 
85, DoseValue, 1935, 1940, "0 . 5", "", 
88, Percentage, 1941, 1942, "%", "", 
89, Diurnal_IOP, 2002, 2015, "diurnal curve", "", 
41, PMID, 2062, 2070, "15094733", "", "<http://ctro/data#Publication_52445> <http://ctro/data#hasPMID> \"15094733\"."
